Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (ACTRN12625000861459) titled 'Upadacitinib versus Oral Corticosteroid for Induction of Transmural Remission in Moderate to Severe Ulcerative Colitis and Crohn's Disease Flares - INDUCE' on Aug. 8.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Mater Misericordiae Ltd
Condition:
Inflammatory Bowel Disease
Ulcerative Colitis
Crohn's Disease
Inflammatory Bowel Disease
Ulcerative Colitis
Crohn's Disease
Oral and Gastrointestinal - Inflammatory bowel disease
Oral and Gastrointestinal - Cro...